Navigation Links
Omnicare and AmerisourceBergen Under Review: Drugs Company Stocks Hit New Highs
Date:2/21/2013

LONDON, February 21, 2013 /PRNewswire/ --

Health-care reforms are expected to bring about paradigm shift in healthcare sectors. However, the major companies are well prepared for such changes. Among others, wholesale drug companies are looking to consolidate their positions in order to be better equipped to face challenges. The stocks are trading on their highs on account of the good performance. AmerisourceBergen Corporation (NYSE: ABC) reported good results and a new collaboration with PharMerica. Similarly, Omnicare Inc. (NYSE: OCR) is getting lapped up Hedge Funds. The stocks are expected to keep up the momentum and perform well. StockCall has released free charting and technical research on these two aforementioned companies. Register to read these reports at

http://www.stockcall.com/report  

AmerisourceBergen Inks Deal with Express Script

AmerisourceBergen's stock hit a new 52-week high. The stock is up 28 percent in the past 52 weeks and seems to maintain the streak. The company also recently announced a 21 cent per share dividend payable on March 4th. Its dividend yield stands at 1.80 percent. AmerisourceBergen reported its fiscal first quarter revenue at $21.5 billion, up 5 percent from $20.3 billion reported a year earlier. Its net income also increased from 62 cents per share to 71 cents apiece. For fiscal 2013, the company expects its earnings to be at $3.16 per share, beating expectations of $3.13 per share. AmerisourceBergen Corporation free technical report can be accessed by signing up at http://www.StockCall.com/ABC022113.pdf  

AmerisourceBergen is expected to keep performing well as the company won a major contract with Express Scripts. The company also renewed its deal with PharMerica, which ensure that the company remains the primary vendor for pharmaceuticals for PharMerica. The deal also makes AmerisourceBergen the primary vendor for California-based Amerita.

AmerisourceBergen is expected to face some tailwinds once health reforms kick in. It also has thin margins and therefore has lesser cushion. However, the company stock is expected to perform well despite its recent run up.

Omnicare Garners Hedge Fund Interest

Omnicare reported good results for its fourth quarter. The company reported its EPS at 86 cents per share, up from 56 cents per share it had reported a year earlier. Its revenue stood at $1.53 billion, down 1.74 percent. The stock has been hitting new 52-week highs lately. It had also been garnering good institutional interest as well. Hedge fund Iridian Asset Management augmented its holding of the company's stock. Omnicare's stock is also held by First Pacific Advisors. Hedge Fund buying is generally considered to be a positive sign for the future growth of the stock. Another major holder of the stock is Oaktree Capital Management. Sign up for the free report on Omnicare Inc. at http://www.StockCall.com/OCR022113.pdf  

However, Omnicare faces some challenges as well. The company is currently restructuring its business to curtail its costs. Late last year, it closed some of its offices and reduced headcounts. It also changed its top management and made some key appointments. The company deals in pharmaceutical care and is mainly operational in Canada and the U.S. It also operates chronic care facilities.

Omnicare's stock gained 6 percent this year so far and is up 11 percent in the past 12 months. The stock also offers 1.45 percent dividend yield. Omnicare recently announced 14 cents per share in quarterly dividend.

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at http://www.stockcall.com


'/>"/>
SOURCE StockCall.com
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Faruqi & Faruqi, LLP is Investigating AmerisourceBergen Corporation on Behalf of its Shareholders
2. Silver Lining Textiles, Manufacturers of Anti-microbial Under Scrub Garments for the Healthcare Industry, Announces Their Availability Through Amazon.com
3. National Patient Advocate Foundation Supports 340B Drug Discount Program Review Identifying Risks to Underinsured Patients
4. Founder of Nestle-Acquired Company Joins Prismic Pharmaceuticals
5. Amgen and Peregrine Under StockCall Scrutiny: Pharma Stocks Deal with Drug Developments and Patents
6. NewLink Genetics Corporation Announces Exercise of Underwriters Option and Closing of Public Offering of Common Stock
7. Underage Kids Get Hydrocodone Drugs Easily from Family & Friends, Advises New York Center for Living
8. Nearly Half of Children Under 2 Years of Age Receive Some Vaccinations Late
9. Starkey Hearing Foundation Founders Bill and Tani Austin Honored by Dalai Lama After Recent Hearing Mission to India
10. Key patent awarded to Adjuvance co-founders for pioneering method of producing rare vaccine component.
11. PIMCO founder Bill Gross and wife, Sue, make transformational gift to Cedars-Sinais Advanced Health Sciences Pavilion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... , July 20, 2017  Prime Therapeutics LLC (Prime) ... Gavras , M.D., following today,s Institute for Clinical and Economic ... on the effectiveness and value of abuse-deterrent formulations (ADF) ... the policy roundtable at the meeting. ... a material cost benefit to the use of abuse-deterrent formulations ...
(Date:7/17/2017)... , July 17, 2017  MedX Holdings, Inc., the ... testing, strengthening and rehabilitation equipment, today announced the national ... MedX is considered the gold standard for the treatment ... specialized medical strengthening equipment. ... with the physician or practice who prescribe the MedX ...
(Date:7/14/2017)... Endo International plc (NASDAQ: ENDP ) will ... Members of its senior management team will host a conference call ... ET. The dial-in number to access the call ... and the passcode is 45397076. Please dial in 10 minutes prior ... A replay of the call will be available from August ...
Breaking Medicine Technology:
(Date:7/23/2017)... ... July 23, 2017 , ... Viora Ltd., a leading medical ... No. 9,038,640 by the United States Patent and Trademark Office. The patent applies ... Switching, Vacuum, and Cooling mechanisms to further increase the efficacy and safety of ...
(Date:7/21/2017)... ... July 21, 2017 , ... "As a doctor of lung medicine ... catheters available on the market," said an inventor from Center Valley, Pa. "My idea ... the patient." , He developed the patent-pending PLEURAL SAFE-t-STAT CATHETER KIT to offer an ...
(Date:7/21/2017)... FL (PRWEB) , ... July 21, 2017 , ... ... insurance management assistance and financial planning services to families and business owners in ... charity event that promises to provide support to area adults with developmental challenges. ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... Theater of Witness , was awarded a $300,000 grant from The Pew Center ... empathy, comfort with ambiguity and the recognition of one’s own limits among health ...
(Date:7/21/2017)... ... ... Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, has written a ... and pleads with world leaders to be more open about positive changes. Yisrayl says the ... there is a peaceful and positive way to solve all; yes, all issues, and he ...
Breaking Medicine News(10 mins):